Side-by-side comparison

NVO vs VRTX — Side-by-side comparison

Neither screens cheaper on EV/FCF, VRTX has the higher ROIC, VRTX has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.

NVO

Novo Nordisk A S

Price

$44.96

Market cap

$305.8B

Day %

N/A

VRTX

VERTEX PHARMACEUTICALS INC / MA

Price

N/A

Market cap

N/A

Day %

N/A

NVO implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

N/A

VRTX implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

N/A

FCF yield

N/A

5Y rev CAGR

14.1%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for NVO.

Grade F

/ 100

Quality Scorecard

Build-time composite score for VRTX.

Grade D

/ 100